Profile picture

Associate Professor Bektas MURAT

Eskisehir City Hospital, Eskisehir (Turkiye)
Membership: HFA Member
Follow
Biography
I was born in 1984. I graduated from the Faculty of Medicine in 2010. I became a cardiologist in 2015, then worked as an interventional cardiologist at Eskisehir Osmangazi University for about a year. I am currently working as a cardiologist at the Ministry of Health Eskişehir City Training and Practice Hospital. I speak, write and listen well Turkish English Persian Uzbek languages Since 2013, I have been conducting academic studies mostly with heart failure and interventional cardiology. I have been working on interventional cardiology since 2019.
Logo ESC

Contributor content

Low LDL-Cholesterol levels predict higher mortality in heart failure with reduced ejection fraction: validating the "lipid paradox" in a real-world cohort
Presentation
Low LDL-Cholesterol levels predict higher mortality in heart failure with reduced ejection fraction: validating the "lipid paradox" in a real-world cohort
Rationale and design of the turkiye heart failure (TURK-HF) registry
Presentation
Rationale and design of the turkiye heart failure (TURK-HF) registry
Digoxin use and heart failure hospitalization in patients with heart failure with preserved ejection fraction: a real-world retrospective analysis
Presentation
Digoxin use and heart failure hospitalization in patients with heart failure with preserved ejection fraction: a real-world retrospective analysis
Back to basics: can a standard 12-lead ECG predict acute pulmonary edema in HFrEF? the superiority of ST-segment depression over LVEF and QRS duration
Presentation
Back to basics: can a standard 12-lead ECG predict acute pulmonary edema in HFrEF? the superiority of ST-segment depression over LVEF and QRS duration
Guideline-directed medical and device therapy use in heart failure with reduced ejection fraction: results from the turkiye heart failure (TURK-HF) registry
Presentation
Guideline-directed medical and device therapy use in heart failure with reduced ejection fraction: results from the turkiye heart failure (TURK-HF) registry
DIAMETER score and its relationship with long-term mortality in heart failure patients with reduced ejection fraction, a novel score
Presentation
DIAMETER score and its relationship with long-term mortality in heart failure patients with reduced ejection fraction, a novel score
Impact of pulmonary valve regurgitation severity on biomarkers, functional capacity, and clinical findings in heart failure patients
Presentation
Impact of pulmonary valve regurgitation severity on biomarkers, functional capacity, and clinical findings in heart failure patients
Pulmonary valve regurgitation severity as a predictor of short-term mortality in heart failure patients: a retrospective analysis
Presentation
Pulmonary valve regurgitation severity as a predictor of short-term mortality in heart failure patients: a retrospective analysis
Real-world use of empaglifozin and dapaglifozin in patients with HEART failure
Presentation
Real-world use of empaglifozin and dapaglifozin in patients with HEART failure
The relationship between anemia and echocardiographic features and all-cause death in patients with heart failure with preserved ejection fraction
Presentation
The relationship between anemia and echocardiographic features and all-cause death in patients with heart failure with preserved ejection fraction

ESC 365 is supported by